Nektar Therapeutics (NASDAQ:NKTR)

Delayed Data
As of Dec 02
 +0.16 / +5.56%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 4.70, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +54.61% increase from the last price of 3.04.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in Nektar Therapeutics. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -43.87%
Growthannually 25.35%


Growthquarterly -6.11%
Growthannually -10.22%
Key to the earnings and sales forecast charts.